International Standards for Cord Blood Collection, Processing, Banking, Selection and Release - AG - Australian Business Licence and Information Service

Description

You must comply with this standard if you intend to use haematopoietic progenitor cells derived from cord blood for any commercial or scientific purpose.

Haematopoietic progenitor cells, otherwise known as stem cells, are used in research and approved experimental medical trials.

Service type

Code of Practice

A code of practice is a set of rules which details how people in a certain industry should behave. A code of practice can be defined as a result of legislation or by industry regulators and bodies.

Other resources

Task	Business Structure	Resources
Comply	All	International Standards for Cord Blood Collection, Processing, Banking, Selection, and Release for Administration (Opens in new window)
Comply	All	Therapeutic Goods Order No. 94 - Standard for Haematopoietic Progenitor Cells derived from Cord Blood (Opens in new window)

Act(s) name

Therapeutic Goods Act 1989 Australian Government (Opens in new window)

Regulation(s) name

Therapeutic Goods Regulations 1990 Australian Government (Opens in new window)

Administering agency

Department of Health and Aged Care

Therapeutic Goods Administration

Contact details

**Please use these contact details for help or more information:**

Enquiries

Therapeutic Goods Administration

Department of Health and Aged Care
Operating address:	136 Narrabundah Lane Symonston, Australian Capital Territory 2609
Mailing address:	PO BOX 100 Woden, Australian Capital Territory 2606
Toll Free:	1800 020 653
Email:	info@tga.gov.au
Website:	Therapeutic Goods Administration (Opens in new window)

International Standards for Cord Blood Collection, Processing, Banking, Selection and Release - Australian Government